Picture EBD Group BioPharm America 2019 Boston September 650x65px

Product › Details

immunotherapy

	Next higher product group	pharmaceutical_o

Record changed: 2019-06-09

More documents for immunotherapy

[1] Imcyse. (6/18/19). "Press Release: Imcyse Secures Total of €35M in Series B Financing Round and Additional Grants". Liège....
[2] Qiagen N.V.. (5/16/19). "Press Release: Qiagen and Inovio Collaborate to Develop Companion Diagnostic for Novel Immunotherapy Targeting Precancerous Cervical Lesions". Hilden, Germantown, MD & Plymouth Meeting, PA....
[3] Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA....
[4] Aimmune Therapeutics, Inc.. (2/28/19). "Press Release: Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights". Brisbane, CA....
[5] Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna....
[6] Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich....
[7] Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA....
[8] Sygnature Discovery Ltd.. (11/8/18). "Press Release: Sygnature Discovery Announces Multi-target Drug Discovery Deal with Sitryx Therapeutics"....
[9] Apitope International N.V.. (10/24/18). "Press Release: Apitope Announces Management Changes. Keith Martin to Retire as CEO, Continue as Non-Executive Director – Hayley French Appointed COO and Interim CEO". Hasselt & Chepstow....
[10] Aimmune Therapeutics, Inc.. (10/15/18). "Press Release: Aimmune Therapeutics Announces Initiation of Phase 2 Study with Regeneron and Sanofi of AR101 with Adjunctive Dupilumab in Peanut-Allergic Patients". Brisbane, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top

Top News

Upcoming Events

Management Appointments

Financings & Acquisitions

Collaborations & Licensing

At Investor Conferences

Bio Regions & Life Sciences Clusters

Business Parks & Science Centres

Associations

Advertise

immunotherapy

More documents for immunotherapy